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Abstract Classic galactosemia is a genetic disorder of galac-
tose metabolism, caused by severe deficiency of galactose-1-
phosphate uridylyltransferase (GALT) enzyme activity due to
mutations of the GALT gene. Its pathogenesis is still not fully
elucidated, and a therapy that prevents chronic impairments is
lacking. In order to move research forward, there is a high
need for a novel animal model, which allows organ studies
throughout development and high-throughput screening of
pharmacologic compounds. Here, we describe the generation
of a galt knockout zebrafish model and present its phenotyp-
ical characterization. Using a TALEN approach, a galt knock-
out line was successfully created. Accordingly, biochemical
assays confirm essentially undetectable galt enzyme activity
in homozygotes. Analogous to humans, galt knockout fish
accumulate galactose-1-phosphate upon exposure to exoge-
nous galactose. Furthermore, without prior exposure to exog-
enous galactose, they exhibit reduced motor activity and im-
paired fertility (lower egg quantity per mating, higher number
of unsuccessful crossings), resembling the human pheno-
type(s) of neurological sequelae and subfertility. In conclu-
sion, our galt knockout zebrafish model for classic galacto-
semia mimics the human phenotype(s) at biochemical and
clinical levels. Future studies in our model will contribute to
improved understanding and management of this disorder.
Introduction
Classic galactosemia is a genetic disorder of galactose metab-
olism, in which there is a severe impairment of galactose-1-
phosphate uridylyltransferase activity (GALT). Patients pres-
ent during the neonatal period with a toxic syndrome, after
ingestion of galactose-containing milk. Though a galactose-
restricted diet is life-saving during this phase, it fails to prevent
the development of chronic impairments affecting mainly
brain and gonads (Antshel et al 2004; Doyle et al 2010;
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Gubbels et al 2011; Kaufman et al 1986; Potter et al 2013;
Rubio-Agusti et al 2013; Schadewaldt et al 2010; Timmers
et al 2012, 2015; Waisbren et al 1983). To date, the exact
pathogenic pathways and their onset are still not fully eluci-
dated. Accumulation of toxic galactose metabolites, such as
galactose-1-phosphate (Gal-1-P) and galactitol (Ross et al
2004; Schadewaldt et al 2003; Slepak et al 2005; Yager et al
2003), aberrant glycosylation (Coss et al 2014; Maratha et al
2016), endoplasmic reticulum (ER) stress (Slepak et al 2007;
Tang et al 2014), GALT misfolding (Coelho et al 2014;
McCorvie et al 2013), and dysregulation of phosphoinositide
3 kinase/protein kinase B (PI3K/Akt) signaling pathway
(Balakrishnan et al 2016) have been implicated.
Animal models for classic galactosemia that tried to mimic
the biochemical and clinical human phenotype(s) have been
developed, a fruit fly (Kushner et al 2010) and two mouse
models (Leslie et al 1996; Tang et al 2014), which have shown
their value (Balakrishnan et al 2016; Chen et al 2017; Daenzer
et al 2016; Jumbo-Lucioni et al 2013, 2014, b, 2016).We have
created a zebrafish model for classic galactosemia that com-
plements these models. The zebrafish model is an ideal inter-
mediate between the invertebrate and the mammalian model
system since it is, as a vertebrate, evolutionary more closely
related to humans while being a more high-throughput system
(high amounts of offspring). Additionally, embryos can be
used as a replacement for adult fish, and embryonic develop-
ment is external, facilitating studies in the prenatal stages. Due
to their transparency and amiability to genetic modification,
different organ systems are easy to study in zebrafish using
reporter lines.
Here, we describe the development of a galt knockout
zebrafish model and present its phenotypical characterization.
This model is meant to improve knowledge on the develop-
mental stage at which lesions occur and for the development
of new therapeutic strategies.
Materials and methods
Ethics statement
This study was approved by the Animal Ethics Committee of
the University of Maastricht (Dier Experimenten Commissie,
Maastricht University) and the Dutch National Central
Authority for Scientific Procedures on Animals (Centrale
Commissie Dierproeven) (AVD107002016545). In addition,
approval was obtained from the Animal Ethics Committee of
the University of Liège (Commission d’Ethique de
l’Utilization des Animaux, Université de Liège, Liège,
Belgium; dossier 1576) for the experiments we performed
initially in the GIGA Zebrafish Facility, Liège. At all times,
the care and use of animals were in agreement with the
national and local guidelines. Care of animals and animal
experiments were conducted exclusively by licensed staff.
Husbandry
Zebrafish (Danio rerio) were housed in recirculating systems
on a 14/10 day-night regime. Husbandry was essentially per-
formed as described by Lawrence (2007).
Generation of galt-deficient zebrafish
The design and assembly of the TALE nuclease (TALEN)
construct targeting the galt gene (ENSDARG00000069543)
to create a knockout was based on the protocol described by
Cermak et al (2011). TALEN coding sequences were obtained
from TAL Effector-Nucleotide Targeter (Bogdanove
Laboratory, Cornell University; (Cermak et al 2011; Doyle
et al 2012)). In order to ensure loss-of-function of the galt
protein, TALEN sequences located within the first part of
the gene were chosen. The DNA binding sites for the
TALEN pair targeting galt were: left site 5′-TTTT
GGTCTCGGCCCATCGG-3 ′ , r ight si te 5 ′-AAAG
GACAGGTGGAGAAA-3′. Constructs were assembled
using the Golden Gate TALEN and Tal Effector Kit 2.0
(Addgene) (Cermak et al 2011). The integrity of the final
constructs was verified by Sanger sequencing. The final
TALEN plasmids were linearized and used as a template for
in vitro mRNA synthesis using the Ambion mMESSAGE
mMACHINE T3 Transcription Kit (Life Technologies).
Subsequently, the mRNA of both left and right TALEN
constructs were injected in wildtype zebrafish embryos in
one-cell stage. Injected fish were raised to adulthood and
outcrossed, followed by confirmation of heterozygotes in the
offspring. Heterozygous fish were incrossed in order to gen-
erate homozygous, galt knockout zebrafish (Fig. 1;
Supplementary Figs. S1 and S2).
Genotyping
Zebrafish embryos were euthanized with a lethal dose of
tricaine. Biopsies from the caudal fin of adult fish were re-
moved with a sharp blade after anesthesia with MS222.
Embryos or fin clips were placed individually in lysis buffer,
consisting of 1M KCl, 1M MgCl2, 1M Tris pH 8.3, NP40,
Tween-20 and gelatine, supplemented with proteinase K to a
concentration of 100 μg/ml. Lysis was performed for 1 h at
60 °C, 15 min at 95 °C, and then held at 4 °C. After adding
80 μl of ultrapure H2O (Milli-Q, Merck Millipore) lysates
were used for PCR.
PCRs encompassing the targeted region of galt were con-
ducted using Phusion Hot Start II DNA Polymerase (Thermo
Scientific) in 50 μl reactions with 5 μl lysate per reaction as
template. The following primers were used (including M13
118 J Inherit Metab Dis (2018) 41:117–127
sequence): forward primer 5′-TGTAAAACGACGGC
CAGTATCGTTTGAAGCCAAAATCG-3′, reverse primer
5′- CAGGAAACAGCTATGACCTGCGTATTTCTCTG
GATTTGC-3′. The PCR product was verified on a 1% aga-
rose gel; 15 μl of the PCR product were combined with 0.5 μl
NcoI restriction enzyme. Reaction mixes were incubated at
37 °C for three hours and then analyzed on a 3% agarose
gel. Mismatches at the targeted region of galt were expected
to result in loss of an NcoI restriction site, thereby generating
two large fragments (526 and 345 bp) rather than three shorter
fragments (408, 118, and 345 bp) (Fig. 2). The presence of a
mutation in only one galt allele will therefore lead to both wild
type and mutant fragments (526, 408, 345 and 118 bp).
Mutations positive by NcoI digestion were confirmed by
Sanger sequencing.
Of PCR product 15 μl were denatured and re-annealed in a
thermocycler by incubation for 2 min at 95 °C, for 10 s at
85 °C, for 15 min at 25 °C, and then held at 16 °C. The re-
annealed products were treated with 0.5 μl of T7 endonucle-
ase I (New England Biolabs) upon addition of 3 μl of buffer
and 11.5 μl of H2O (Milli-Q, Merck Millipore) to a final
volume of 30 μl. Reaction mixes were incubated for 20 min
at 37 °C and analyzed on a 3% agarose gel. Mismatches at the
targeted region of galt were expected to result in cleavage of
heteroduplexes, thereby generating additional fragments.
Mutations positive by T7 endonuclease I were confirmed by
Sanger sequencing.
To enable large-scaled genotyping, a high resolution melt-
ing (HRM) analysis was applied (Wittwer et al 2003). Primers
were designed using Primer3 software (Untergasser et al
2012) (forward primer 5′-TACAATCCTCTGCGGGACTC-
3′; reverse primer 5′-CGTGGGATGTTGTCCTCTG-3′).
Amplification and HRM analysis were performed in the
LightCycler ®480 (Roche Applied Science), using the High
Resolution Melting Master kit (Roche Applied Science). Both
genotype A and genotype B amplicons were analyzed accord-
ing to the following conditions: 95 °C for 10 min; 45 cycles of
95 °C for 10 s, 59 °C for 15 s, 72 °C for 15 s; one cycle of
95 °C for 60 s, 40 °C for 60 s, and a melting from 60 to 95 °C
rising at 0.02 °C per second. All samples were run in triplicate.
HRM analysis was performed using the software LightCycler
® 480 Gene Scanning version 1.5.1.
Gene expression analysis RT-PCR
RNA was extracted from single adult organs using TRIzol
(Life Technologies). A qScript cDNA Synthesis Kit
(Quantabio) was used to generate cDNA. Quantitative real-
time PCR (qPCR)-based quantification of galt, galk1
(galactokinase), gale (UDP-galactose 4′-epimerase), and
akr1b1 (aldose reductase) expression was conducted, with
ef1a as a reference gene (Tang et al 2007). Primer sequences
are available on request. SYBR® green (Bioline) was used for
all qPCR experiments. Samples, obtained from two indepen-
dent RNA extractions were measured five times in total.
Zebrafish galt activity
The galt activity was analyzed in embryos (5 days post fertil-
ization, dpf) and adult fish. Thirty zebrafish embryos were
Fig. 1 Galactose metabolism in
humans and zebrafish. Genes
encoding the enzymes involved in
galactose metabolism (panel a) in
humans show strong conservation
with their zebrafish counterparts
(panel b). Strikingly, only the
UGP2 gene is duplicated in
zebrafish (ugp2a and ugp2b).
GALK1: galactokinase, GALT:
Galactose-1-phosphate
uridylyltransferase, GALE: UDP-
galactose 4′-epimerase, UGP:
UDP-glucose/UDP-galactose
pyrophosphorylase, Panel b
shows the percentage of amino
acid similarity between the hu-
man and zebrafish homologs of
the enzymes involved in galactose
metabolism
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Fig. 2 Establishment of a galt knockout model. Panel a shows the
genomic layout of the zebrafish galt gene. Injection of galt-specific
TALEN constructs, targeting exon 2, resulted in two different genotypes
(A and B), both leading to a predicted frame-shift and a premature stop
codon. Full length wildtype galt consists of 364 amino acids. Mutant
protein in genotype A consists of the first 61 amino acids of the wildtype
protein, followed by 26 amino acids that differ fromwildtype galt. Mutant
protein in genotype B consists of the first 58 amino acids of the wildtype
protein, followed by 29 amino acids that differ from wildtype galt. The
two genotypes of galt knockout zebrafish could be identified by NcoI, T7
endonuclease I and HRM analysis. Panel b illustrates a representative
pattern of NcoI analysis of genotype A. Panel c illustrates a representative
pattern for HRM analysis for genotype A or B (pink: wildtype, blue:
heterozygous, green: knockout). Panel d shows a severe impairment of
the galt catalytic activity in larval wildtype and knockout zebrafish (5dpf)
using a HPLC assay
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suspended in 300 μL lysis buffer containing 80 mM Tris
pH 8.0 and cOmplete mini EDTA-free Protease Inhibitor
(Roche). The suspension was homogenized in a potter tube
(10 strokes) and subsequently sonicated by the ultrasonic pro-
cessor UP50H (Hielscher) with a 2 mm diameter tip, ampli-
tude 175 μm, power density 480 W/cm2. Lysates were centri-
fuged at 11,500 × g for 20 min at 4 °C. 50 μL of the superna-
tant, diluted to contain 30 μg of protein (assessed with BCA
Protein Assay Kit), were mixed with 0.4 mM dithiothreitol,
30 mM Gal-1-P, 125 mM glycine and 15 mM UDP-glucose
(UDP-Glc), and subsequently incubated for 60 min at 28 °C.
The reaction mix was further processed and analyzed by
HPLC as described previously (Lindhout et al 2010).
Moreover, two reaction mixes were used as controls, one con-
taining 0.4 mM dithiothreitol, 125 mM glycine, and 15 mM
UDP-Glc (no Gal-1-P), and the other containing 0.4 mM di-
thiothreitol, 30 mM Gal-1-P, and 125 mM glycine (no UDP-
Glc). Gal-1-P, UDP-Glc, UDP-Gal, dithiothreitol, and glycine
were purchased from Sigma-Aldrich/Fluka (Zwijndrecht, the
Netherlands).
Additionally, galt activity was analyzed in adult fish (brain,
ovary, and skeletal muscle) through a liquid chromatography
tandem mass spectrometry (LC-MS/MS) as previously de-
scribed (Li et al 2011). Briefly, incubation medium consisted
of 16 μL of 0.5 M glycine buffer pH 8.7, 8 μL of 2 mMUDP-
Glc, 8 μL of 2 mM 13C6-Gal-1-P, and 8 μL of 4 mg/mL tissue
lysate and incubated at 30 °C water bath for 30 min. All
samples were prepared in duplicate and measured twice.
13C2-Gal-1-P and
13C6-Gal-1-P were purchased from
Omicron Biochemicals Inc. (South Bend, IN, USA). Glycine
(culture grade) was purchased from Fisher Scientific
(Waltham, MA, USA). All other chemicals were obtained
from Sigma (St. Louis, MO, USA).
Zebrafish galk1 activity
Catalytic galk1 activity was measured in ovarian samples.
Gonads were added to a tube containing PBS buffer, 1% pro-
teinase inhibitor cocktail (Sigma-Aldrich), and lysed by soni-
cation at 4 °C. Protein measurement, galk1 assay, and LC-MS/
MS were performed as previously described (Li et al 2014),
except that 1 mg/mL ovarian lysate were added to the assay
co-factors cocktail and incubated at 30 °C for 30 min. Briefly,
galk1 assay consisted of 12.5 μL of 2 mM 13C6-galactose,
12.5 μl of 0.8 mol/L MOPS buffer pH 7.8, 12.5 μL mixture
of co-factors cocktail (30 mM ATP, 32 mM MgCl2 and
32 mM NaF) with 25 μl of 6 mg/mL ovarian lysate. Two
standard tubes were then put in 30 °C water bath for 1 h and
100 °Cwater bath for 3 min. One blank tube was put in 100 °C
water bath for 3 min and 30 °C water bath for 1 h. After
finishing incubation 20 μL of 100 μM internal standard,
13C2 Gal-1-P, with 96 μL acetonitrile were added to the tube.
It was roughly vortex for 30 s and centrifuged at 14,000 × g
for 10 min, 50 μL of supernatant was added to autosampler
vial which contained 950 μL 80% acetonitrile for LC-MS/MS
analysis. Calibrator concentrations of galk1 were 200, 100,
33.3, 11.1, 3.7, and 1.23 μmol/L.
Liquid chromatography, mass spectrometry (MS), column,
and data analysis were similar to gale method but with differ-
ent transitions and LC-MS settings. All samples were pre-
pared in duplicate and measured twice. 13C6-Gal was pur-
chased from Omicron Biochemicals Inc. (South Bend, IN,
USA).
Zebrafish gale activity
Frozen tissues were added to a tube containing 0.5 mol/L
glycine pH 8.5 (Sigma-Aldrich), 1% proteinase inhibitor
cocktail (Sigma-Aldrich), and lysed by sonication at 4 °C.
Protein measurement, gale assay, and LC-MS/MS settings
were the same as previously described (Li et al 2014) except
that 20 μl of 4 mg/ml of brain or 1 mg/ml ovarian lysate were
added to the cocktail and incubated at 30 °C for 30 min. 13C3-
UDP-Glc (Sigma-Aldrich) was added as internal standard. All
samples were prepared in duplicate and measured twice.
Zebrafish ugp activity
The ugp activity was measured in brain, ovary, and skeletal
muscle, in a reaction mixture consisting of 4.35 μL of 0.5 M
glycine buffer pH 8.7 (Sigma-Aldrich), 4.35 μL of 0.66 mM
UTP, 4.35 μL of 4 mM 13C6 Glc-1-P, 1.96 μL of 6 mM
MgCl2, and 5 μL of 1 mg/ml tissue lysate and incubated at
30 °C for 3 min. The reaction was stopped by adding 45 μL of
a mixture composed of 7.8 μL of 20 μM 13C3 UDP-Glc,
31.2 μL of acetonitrile, and 6 μL of 0.6 M formic acid.
After mixing and centrifugation at 14000 × g for 10 min,
30 μL of the supernatant was used for LC-MS/MS analysis.
Calibrator concentrations of ugp were 111, 37, 12.3, 4.1, 2.05,
and 1.03 μmol/L. All samples were prepared in duplicate and
measured twice. All chemicals and reagents were purchased
from Sigma-Aldrich.
Gal-1-P evaluation
In order to measure Gal-1-P in zebrafish, embryos were
suspended in 300 μl lysis buffer containing 80 mM Tris
pH 8.0 (Sigma-Aldrich) and Complete mini EDTA-free
Protease Inhibitor (Roche). The suspension was homogenized
in a potter tube (10 strokes) and subsequently sonicated by the
ultrasonic processor UP50H (Hielscher) with a 2 mmdiameter
tip, amplitude of 175 μm, and power density of 480 W/cm2.
Lysates were centrifuged at 11,500 × g for 20min at 4 °C. Gal-
1-P content was then determined in 70 μl of the supernatant,
by a coupled-enzyme assay, as described in (Bosshard and
Steinmann 2008). Briefly, in the first reaction, Gal-1-P is
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converted into galactose by alkaline phosphatase (AP), and in
the second reaction, galactose is converted into galactone by
galactose dehydrogenase (GDH). In the second reaction,
NAD+ is used as a co-substrate by GDH, thus leading to the
production of NADH, which was determined UV-
spectrophotometrically (λ = 340 nm).
Accordingly, Gal-1-P quantification was carried out using
two mixes: the first containing 160 mM Tris pH 8.6, NAD+
12.5 mM, 43,000 U/ml AP and 60 U/ml GDH (galactose and
Gal-1-P), and the second containing 160 mM Tris pH 8.6,
NAD+ 12.5 mM and 60 U/ml GDH (galactose). A mix con-
taining no enzyme was also prepared and used as blank. Gal-
1-P concentration was calculated by subtracting total galac-
tose (determined from reaction 2) to total galactose and Gal-1-
P (determined from reaction 1), and normalized to zebrafish
and protein content. Total protein was quantified using the
BCA Protein Assay Kit (Thermo Scientific) (Smith et al
1985).
Development and survival evaluation
Development and survival of all fish was compared between
genotypes from 5 dpf until adulthood, in the absence of expo-
sure to galactose. At the age of 5 dpf morphology was studied
with microscopy. Specific attention was paid to hatching and
swim bladder development. Abnormal fish were genotyped to
evaluate whether the three different genotypes (wildtype, het-
erozygous, knockout) were disproportionally present in these
fish. Assessment of survival rates, and comparison between
genotypes, was conducted on a daily basis throughout the
embryonic phase, and monthly thereafter.
Galactose challenge
Wildtype and knockout embryos (n = 30 per genotype) of 24 h
post fertilization (hpf) were exposed to different concentra-
tions of galactose-containing E3 medium (50–300 mM) in
100 mm petri dishes. Unexposed wildtype and knockout em-
bryos (n = 30 per genotype) grown in E3 medium were used
as a control. All animals were monitored daily for viability
until they reached 5 or 9 days of age.
Fertility evaluation
A selected pool of unchallenged, adult age-matched galt
wildtype (n = 24; 12 fish per tank), heterozygous (n = 12;
two tanks of 6 fish plus 6 TL fish, total of 12 fish per tank)
and knockout zebrafish (n = 24; 12 fish per tank) (n = 60) was
crossed periodically (total of 10 crossings), to explore fertility
in the different genotypes. The following crossings were con-
ducted (six pairs per condition): wildtype incross, heterozy-
gous incross, knockout incross, wildtype female crossed to
knockout male, and knockout female crossed to wildtype
male. This sample size was determined as the maximum num-
ber of crossings which was practically possible. Mass mating
of wildtype and knockout fish (five pairs per genotype; total of
five crossings) was also performed. The number of eggs and
egg quality per spawning event per genotype were assessed.
Egg quality was assessed immediately after spawning and at
24 hpf to evaluate initial egg quality and fertilization rate,
respectively. Inclusion criteria for fertility analysis; successful
crossing was defined as an event where >10 fertilized eggs
were produced per pairwise mating. This criterion was
established before experiments were started.
Neurological assessment
Zebrafish embryos (5 dpf) and juveniles (4 weeks old) were
placed in 24- and 12-well plates, respectively. Motor activity
was quantified using a ZebraBox (Viewpoint) device under
exposure to light for a period of 60 min. Activity is expressed
as an average number of changes in pixels (arbitrary units)
throughout the experiment. Motor activity was evaluated
and compared between genotypes.
Statistical analyses
Levene’s test was used as a preliminary screen for homogene-
ity of variances between or among groups with equal n values
and the Brown–Forsythe test was used for groups with un-
equal n values. Differences between two groups were evalu-
ated for statistical significance using an independent t-test
(two-tailed), and differences between more than two groups
were evaluated for statistical significance by one-way analysis
of variance (ANOVA).
The number of unsuccessful crossings exhibited by each
knockout group was compared with that of wildtype pairs by
chi square analysis (Fisher’s exact test, double-sided). Egg
quality was evaluated by quantifying the amount of viable
and unviable eggs immediately after spawning and at 24 hpf
(unsuccessful crossings excluded), and the ratio of the average
viable eggs per mating was compared between groups by non-
parametric, one sample analysis.
For all tests a p value less than 0.05 was considered statis-
tically significant.
Results
Zebrafish metabolize galactose via the Leloir pathway
To explore the role of galactose metabolism in zebrafish, we
first confirmed that the zebrafish genome encodes and ex-
presses orthologues of the human genes encoding the Leloir
pathway enzymes (GALK1, GALT, GALE) and the enzymes
involved in escape routes (AR, UGP) (Fig. 1). A BLAST
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search identified a single zebrafish orthologue of human
GALT on chromosome 10 of the zebrafish genome
(ENSDARG00000069543). The zebrafish galt gene has two
protein coding transcripts, of which the first (galt-001,
ENSDART00000138161) encodes a protein of 364 amino
acids and shows the strongest conservation with the human
orthologue (73%) (Fig. 1). Despite the fact that fish underwent
a genome duplication throughout evolution (Howe et al 2013),
theUGP2 gene is the only duplicated gene related to galactose
metabolism in zebrafish (Fig. 1).
galt TALEN-generated mutants are loss-of-function
TALENmRNA pairs targeting exon 2 of galtwere injected in
AB wildtype zebrafish embryos in the one-cell stage. A con-
centration of 150 pg of both TALEN mRNAs were injected
after assessing toxicity and as a function of injection dose at
24 hpf. NcoI and T7 endonuclease I genotyping, followed by
Sanger sequencing confirmation, revealed the generation of
two galt mutant genotypes (Fig. 2a and b). Genotype A
(c.106_112delCGTCCAT) represents a 7 bp deletion, leading
to a frame-shift at position c.106 and a subsequent introduc-
tion of a premature stop codon 26 amino acids downstream;
the mutation is positive by NcoI and T7 endonuclease I anal-
yses (Fig. 2b; Supplementary Fig. S2). Genotype B
(c.[106_107delCG; 106_109insGACA]) consists of a 2 bp
deletion and 4 bp insertion, leading to a frame-shift at position
c.106 and introduction of a premature stop codon 29 amino
acids downstream; the mutation is negative by NcoI digestion
and positive by T7 endonuclease I analysis. Genotype A and
B presented the same melting profile by high resolution melt-
ing (HRM) analysis (Fig. 2c).
The galt enzyme activity was essentially null in knockout
embryos at 5 dpf (3.1%; Fig. 2d), confirming at the biochem-
ical level that the knockout represents a loss-of-function allele.
The galt enzyme activity was undetectable in the brain or
ovary of adult knockout fish, the target organs of long term
damage in classic galactosemia (Fig. 3a and b), as well as in
skeletal muscle (Supplementary Fig. S3).
galt knockout embryos accumulate Gal-1-P after exposure
to galactose
To identify susceptibility to galactose, knockout embryos
were challenged with different concentrations of galactose,
of which a concentration of 200 mM galactose was chosen
to proceed with the galactose challenge studies. In order to
avoid inducing early developmental effects, embryos were
exposed to galactose for 24 hpf onward till the ages indicated.
When exposed to exogenous galactose, knockout embryos
accumulated high amounts of Gal-1-P at 5 dpf as compared to
the unexposed situation and to wildtype fish (Fig. 3c).
At 9 dpf, knockout fish accumulated asignificant amount of
Gal-1-P in the absence and presence of galactose. Wildtype
fish presented low Gal-1-P levels in the absence of exogenous
galactose, whereas in the exposed situation accumulated
higher Gal-1-P levels (Fig. 3d).
galk1, gale, ugp activity
Catalytic activity of galk1, gale, and ugp—other enzymes of
galactose metabolism—was also measured in adult fish. The
galk1 activity was measured in the ovary, which revealed no
statistically significant difference between knockout and
wildtype fish (p = 0.83). The gale activity measured in the
brain and ovary, and was shown to be marginally elevated in
brain (p = 0.16) and slightly reduced in the ovary of knockout
animals (p = 0.21) comparatively to wildtype. The gale en-
zyme activity was 8–10 fold higher in the ovary than in brain,
both in knockout (p = 0.0056) and wildtype animals
(p = 0.0069). Activity of ugp was also not significantly differ-
ent in knockout versus wildtype ovary and brain (p = 0.26 and
p = 0.38, respectively), with no clear difference in activity
between these two tissues (Fig. 3a and b). Muscle ugp activity
revealed that the knockout fish had more than 2 times higher
that of the wildtype animals (p = 0.034; Supplementary Fig.
S3). In addition, we assessedmRNA expression levels in adult
brain and ovary of knockout animals vs. controls (Fig. 3e).
Transcriptional analysis revealed galk1 and gale mRNAwere
more than two-fold higher in ovary of knockout fish
(p = 0.0014 and p = 0.025, respectively).
Normal development and growth
Unchallenged galt knockout fish undergo normal develop-
ment and growth: hatching, swim bladder development, mor-
phology or survival rate are not affected throughout embryo,
juvenile or adult stages. Thus, galt knockout zebrafish are
morphologically indistinguishable from heterozygotes and
wildtype fish; growth and survival rates are similar (data not
shown).
Fertility evaluation
Heterozygous pairs did not exhibit a statistically significant
difference in egg quantity (p = 0.106; 95% confidence interval
was of −73.0 ± 44.6) or quality as compared to wildtype pairs
(p = 0.228; 95% confidence interval was of −38.9 ± 31.9).
Knockout pairs, wildtype female/knockout male, and
knockout female/wildtype male exhibited a lower egg quanti-
ty per mating as compared to wildtype pairs (Fig. 4b;
p = 0.044).
The number of unsuccessful crossings revealed a statis-
tically significant difference between knockout pairs and
knockout female/wildtype male comparatively to wildtype
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pairs (p = 0.012 and p = 0.022, respectively). The number
of unsuccessful crossings was not statistically significantly
different between wildtype female/knockout male and
wildtype pairs (p = 0.199). There was a higher frequency
of unsuccessful crossings whenever a knockout female
was involved (Fig. 4c).
Egg quality was analyzed by the average ratio of viable
eggs at 24hpf, excluding unsuccessful crossings. Non-para-
metric, one sample analysis revealed that there is no statisti-
cally significant difference between the egg quality laid by any
of the groups (p = 0.662). Egg quality seems to be unaffected
in galt knockout fish (Supplementary Fig. S4).
Mass mating revealed a higher number of eggs in wildtype
fish (Supplementary Fig. S5).
Neurological assessment
Knockout embryos (5 dpf) showed similar activity as wildtype
controls, both without (p = 0.472) and with (p = 0.114) prior
exposure to exogenous galactose (data not shown). At a later
stage, unchallenged 4 weeks old knockout juvenile fish
showed a statistically significant lower activity than age-
matched wildtype control (p = 0.004) (Fig. 4a).
Fig. 3 Biochemical phenotype of galt knockout zebrafish. Panel a and b:
galt knockout fish demonstrated essentially null galt activity in adult
brain (panel a) and ovaires (panel b) using an LC-MS/MS method.
Enzyme activity of indicated enzymes is plotted per genotype as the
average activity +/− SD. ND: not detectable. Sample sizes were: in
brain (panel a); galt activity wildtype and knockout: n = 5; gale activity
wildtype n = 10 and knockout n = 8; ugp activity wildtype and knockout
n = 5. In ovary (panel b); galt activity wildtype n = 5 and knockout: n = 4;
gale activity wildtype and knockout n = 3; ugp activity wildtype and
knockout n = 3. Panel c: When challenged with 200 mM of galactose
for 5 days (1dpf-5dpf), knockout zebrafish accumulated high
concentrations of Gal-1-P, whereas levels remained essentially null in
wildtype zebrafish. Values are from two independent experiments
(n = 2) and are presented as ratio of knockout Gal-1-P when exposed to
galactose. Panel d:When challengedwith 200mMof galactose for 8 days
(1dpf-9dpf), knockout zebrafish accumulated high concentrations of Gal-
1-P, whereas levels remained low in wildtype zebrafish. Values are from
two independent experiments (n = 2) and are presented as ratio of knock-
out Gal-1-P when exposed to galactose. Panel e: mRNA expression levels
of 4 key enzymes of the Leloir pathway was evaluated by QPCR. Values
are given as expression fold change of the knockout compared to the
wildtype tissues. Measurements were performed 5 times, each in triplicate
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Discussion
Herein we describe the successful development and character-
ization of a zebrafish model for classic galactosemia.
The galt knockout zebrafish mimics the human phenotype
at both the biochemical and clinical levels. Enzymatic assays
confirmed successful loss-of-function, with essentially null
galt activity. Additionally, knockout fish accumulated
elevated concentrations of Gal-1-P, which was exacerbated
upon exposure to exogenous galactose. Catalytic activity of
galk1, gale, and ugp were also measured, and interestingly
varied considerably in the various tissues, which probably
reflect specific needs of the given organ (Adeva-Andany
et al 2016; Coelho et al 2017; Walter and Fridovich-Keil
2014). In contrast with their specific activity which was essen-
tially the same as in wildtype fish, galk1 and galemRNAwere
significantly higher in ovary of knockout fish, suggesting that
specific cellular signaling in knockout fish possibly increased
galk1 and gale transcription, repressed galk1 and gale synthe-
sis and/or increased galk1 and gale turnover.
Whereas knockout larvae exhibited a motor activity indis-
tinguishable of that of wildtype larvae, on the long term,
knockout fish showed a significantly decreased motor activity
as compared to that of wildtype fish, despite no prior exposure
to exogenous galactose. Furthermore, the reproductive capac-
ity in adult knockout zebrafish without previous exposure to
exogenous galactose was decreased as compared to wildtype
fish, presenting a lower egg quantity and a higher frequency of
unsuccessful crossings. Even though to a lower extent than
female fish, knockout male fish also appear to have impaired
fertility. The decrease in motor activity might to some extent
have influenced mating behavior and indirectly also affected
the reproductive capacity.
These findings are in line with the human phenotype, in
which patients present a severely impaired GALT activity and
accumulate high levels of Gal-1-P, particularly in the newborn
period upon exposure to galactose-containing milk
(Schadewaldt et al 2003). Regarding the chronic complica-
tions, the observed brain and gonadal impairments in unex-
posed galt knockout zebrafish are in line with the human phe-
notype of neurological and ovarian sequelae, which occur
even in patients that have had galactose restriction from their
first day of life (Hughes et al 2009; Rubio-Agusti et al 2013;
Waisbren et al 2012). Impaired male fertility in fish is in line
with previous reports of a possible not clinically relevant male
fertility impairment (Gubbels et al 2013).
Moreover, the clinical findings in our zebrafish model are
in line with observations in other animal models for classic
galactosemia. GALT-deficient flies exhibited motor impair-
ments (Kushner et al 2010), whereas GALT-deficient mice
exhibited brain abnormalities, and females showed a smaller
litter size and longer time to achieve pregnancy (Chen et al
2017; Tang et al 2014).
With the creation of our zebrafish line, we have generated a
model that complements these existing models by allowing
the study of organ development from embryo stage to adult-
hood, which can provide important new insights on when
lesions of target organs occur in galactosemia. Hitherto, it
remains to be elucidated whether organ toxicity has a prenatal
or postnatal onset, or extends over multiple developmental
stages. Though the fly and mouse models already
Fig. 4 Chronic impairments. Impairments of motor activity and fertility
were observed in galt knockout zebrafish never exposed to exogenous
galactose. Reduced motor activity was observed in knockout juvenile fish
(4 weeks old) as compared to matched controls (n = 66 per genotype;
motor activity expressed as mean ± SEM from two independent
measurements) (panel a). Adult knockout pairs, wildtype female/
knockout male and knockout female/wildtype male exhibited a lower
average egg quantity per mating as compared to wildtype pairs (panel
b; expressed as mean ± SEM from 10 independent crossing events). The
number of unsuccessful crossings was higher in the presence of a knock-
out female (panel c)
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demonstrated great importance for pathogenesis studies, the
zebrafish model is more amenable to organ studies throughout
development, which are essential to answer the long-standing
open question if, and to what extent, prenatal organ damage
occurs. The availability of transgenic reporter lines and acces-
sibility to sophisticated imaging techniques allow studying
folliculogenesis and neurogenesis from embryonic stage to
adulthood. In addition, the high-throughput screening poten-
tial of our model facilitates rapid and efficient testing of phar-
macologic compounds.
In conclusion, we have successfully developed a galt
knockout zebrafish model, which phenocopies the human
hallmarks of classic galactosemia at both the biochemical
and clinical levels. Notably, we show that brain and gonadal
impairments are present despite no previous exposure to ex-
ogenous galactose. We generated this model because of the
unique features of the zebrafish that allow studies on onset of
damage and development of new therapeutic strategies.
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